ft 22 jun 92 intern compani news smithklin italian co promot drug deal smithklin beecham anglo american healthcar consum group sign co promot deal sigma tau italian privat healthcar compani sell drug us degen disord includ alzheim diseas sigma tau alreadi worldwid co market agreement roch switzerland drug known alcar three compani promot drug togeth alcar launch itali 1986 present phase iii trial us result us trial involv 400 patient 27 clinic trial site expect first quarter next year previou trial itali show drug could retard dementia alzheim diseas improv attent span long term memori verbal abil meanwhil smithklin develop two drug oxiracetam denbufyllin treatment alzheim compani said agreement would affect develop ad experi group gain market alcar would help later sell compound us food drug administr investig report individu smoke use nicotin patch heart attack said hospit massachusett report five heart attack patient use nicotin patch smoke